U.S. Markets closed

Top Ranked Momentum Stocks to Buy for December 10th

Zacks Equity Research

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, December 10th:

RH (RH): This retailer of home furnishings has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing nearly 7% over the last 60 days.

RH Price and Consensus

RH Price and Consensus

RH price-consensus-chart | RH Quote

RH’s shares gained 35.9% over the last one month above the S&P 500’s increase 1.6%. The company possesses a Momentum Score of A.

RH Price

RH Price

RH price | RH Quote

Target Corporation (TGT): This general merchandise retailer has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.7% over the last 60 days.

Target Corporation Price and Consensus

Target Corporation Price and Consensus

Target Corporation price-consensus-chart | Target Corporation Quote

Target Corporation’s shares gained 14.5% over the last one month. The company possesses a Momentum Score of A.

Target Corporation Price

Target Corporation Price

Target Corporation price | Target Corporation Quote

Tilly's, Inc. (TLYS): This retailer of casual apparel, footwear, and accessories for young men and women, and boys and girls has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6% over the last 60 days.

Tilly's, Inc. Price and Consensus

Tilly's, Inc. Price and Consensus

Tilly's, Inc. price-consensus-chart | Tilly's, Inc. Quote

Tilly's shares gained 21.7% over the last one month. The company possesses a Momentum Score of A.

Tilly's, Inc. Price

Tilly's, Inc. Price

Tilly's, Inc. price | Tilly's, Inc. Quote

Cassava Sciences, Inc. (SAVA): This clinical-stage drug development company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing nearly 29% over the last 60 days.

Cassava Sciences Price and Consensus

Pain Therapeutics Price and Consensus

Cassava Sciences price-consensus-chart | Cassava Sciences Quote

Cassava Sciences’ shares gained 32.5% over the last one month. The company possesses a Momentum Score of B.

Cassava Sciences Price

Pain Therapeutics Price

Cassava Sciences price | Cassava Sciences Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Today's Best Stocks from Zacks

Would you like to see the updated picks from our best market-beating strategies? From 2017 through Q3 2019, while the S&P 500 gained +39.6%, five of our strategies returned +51.8%, +57.5%, +96.9%, +119.0%, and even +158.9%.

This outperformance has not just been a recent phenomenon. From 2000 – Q3 2019, while the S&P averaged +5.6% per year, our top strategies averaged up to +54.1% per year.

See their latest picks free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Tilly's, Inc. (TLYS) : Free Stock Analysis Report
 
Target Corporation (TGT) : Free Stock Analysis Report
 
Pain Therapeutics (SAVA) : Free Stock Analysis Report
 
RH (RH) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research